ALLO Earnings

Quarterly EPS
$-0.32
Q3 2024
$-0.28
Q4 2024
$-0.28
Q1 2025
$-0.23
Q2 2025
$-0.19
Q3 2025
$-0.17
Q4 2025
$-0.18
Q1 2026
$-0.13
Q2 2026
Latest Revenue4.6M
Latest Net Income-42677000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.134.6M-42677000+43.5%
Q1 2026-$0.180-42607000+35.7%
Q4 2025-$0.170-38810000+39.3%
Q3 2025-$0.190-41400000+40.6%
Q2 2025-$0.230-50943000+34.3%
Q1 2025-$0.280-59733000-100.0%+26.3%
Q4 2024-$0.280-59939000-100.0%+45.1%
Q3 2024-$0.320-66293000-100.0%+13.5%
Q2 2024-$0.350-66358000
Q1 2024-$0.3822.0K-65000000
Q4 2023-$0.5121.0K-85778000
Q3 2023-$0.3722.0K-62287000
Allogene Therapeutics (ALLO) — Earnings